Sevelamer

Sevelamer (rINN) (/sɛˈvɛləmər/ or /sɛˈvɛləmɪər/) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is currently marketed by Sanofi under the trade names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate).

单词	Sevelamer Hydrochloride
释义	Sevelamer Hydrochloride 英语百科 Sevelamer Sevelamer (rINN) (/sɛˈvɛləmər/ or /sɛˈvɛləmɪər/) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is currently marketed by Sanofi under the trade names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate).
随便看	ulcer of cervix ulcer of cornea Ulcer of cystic duct Ulcer of esophagus Ulcer of foot Ulcer of gallbladder ulcer of gastroenteric stoma ulcer of gums Ulcer of larynx Ulcer of leg ulcer of lingaal frenum Ulcer of lip ulcer of lower limb Ulcer of mouth Ulcer of nasal septum ulcer of nipple ulcer of nose ulcer of oral cavity ulcer of penis ulcer of prepuce Ulcer of prostate ulcer of pyloric canal Ulcer of rectum ulcer of rheumatoid arthritis ulcer of sclera

Sevelamer Hydrochloride

Sevelamer